Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Surfactant deficiency disease (SDD) favored term
a.k.a. respiratory distress syndrome & hyaline membrane disease (archaic)
Common lung disease occurring in premature infants due to lack of surfactant
Microatelectasis & abnormal pulmonary compliance are hallmarks of disease
Premature infants < 32-week gestation at risk
Initial findings are low lung volumes & diffuse granular opacities
Signs of tension (lung collapse, mediastinal shift) less likely if pneumothorax develops (due to ↓ lung compliance)
High incidence of patent ductus arteriosus, leading to pulmonary edema (“whiteout” of lungs with cardiomegaly)
Bronchopulmonary dysplasia (BPD) eventually occurs in 17-55% of premature infants
Surfactant normally coats alveoli & ↓ surface tension, allowing alveoli to stay open
Prematurity-related SDD: Immature type II pneumocytes cannot produce sufficient surfactant
Secondary SDD: Surfactant deactivation from meconium aspiration or infection
Primary SDD: Dysfunctional surfactant due to abnormalities of 1 of several gene products
Respiratory distress, usually with history of prematurity
Acute complications: Alveolar rupture with barotrauma (pneumothorax, pneumomediastinum, PIE)
Chronic complications: BPD, ↑ incidence of sudden death
Treatment
Prenatal prevention (delay delivery, maternal steroids)
Surfactant administration
Mechanical ventilation + positive end-expiratory pressure
Surfactant deficiency disease (SDD) = lung disease of prematurity, respiratory distress syndrome, hyaline membrane disease (archaic)
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here